Ekos nets CE mark for pulmonary embolism device
Ekos has announced its EkoSonic endovascular system has received the CE mark for the treatment of pulmonary embolism (PE).
The EkoSonic system, which was originally designed and approved to dissolve blood clots in the arms and legs, now has the added indication for treating PE.
Nils Kucher, MD, from the University Hospital of Bern in Switzerland, principal investigator of the ULTIMA (Ultrasound Accelerated Thrombolysis of Pulmonary Embolism) trial launched in 2010, emphasized, “Because the Ekos system incorporates into the catheter body small ultrasound transmitters which condition the clot to more rapidly absorb the thrombolytic drug, it can dissolve the clot faster.”
The EkoSonic system, which was originally designed and approved to dissolve blood clots in the arms and legs, now has the added indication for treating PE.
Nils Kucher, MD, from the University Hospital of Bern in Switzerland, principal investigator of the ULTIMA (Ultrasound Accelerated Thrombolysis of Pulmonary Embolism) trial launched in 2010, emphasized, “Because the Ekos system incorporates into the catheter body small ultrasound transmitters which condition the clot to more rapidly absorb the thrombolytic drug, it can dissolve the clot faster.”